Metabolomics of Prostate Cancer and Clinical Profiles Following Radiotherapy: Need for a Precision Phylometabolomics Approach †
Hakima Amri, Charles Sturgeon, David Posawatz, Mones Abu-Asab, Ryan R Collins, Simeng Suy, Sean P Collins, Giuseppe Lucarelli, Francesco Lasorsa · 2025
Read Metabolomics of Prostate Cancer and Clinical Profiles Following Radiotherapy: Need for a Precision Phylometabolomics Approach † by Hakima Amri, Charles Sturgeon, David Posawatz, Mones Abu-Asab, Ryan R Collins, Simeng Suy, Sean P Collins, Giuseppe Lucarelli, Francesco Lasorsa (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731751.txt.
Description
Hakima Amri and co-authors profile in 2025 the blood chemistry of prostate cancer patients before and after focused radiation. Small molecules in the blood reflect how a body and its tumor respond to treatment. Grouping patients by shared chemistry patterns might reveal who benefits and who does not.
Serum samples from 55 patients were read by mass spectrometry and sorted by a parsimony method borrowed from family-tree science. Five chemistry groups emerged after treatment, and they did not line up with hormone therapy, risk class, or spread of the cancer. The usual PSA blood test failed to predict group membership. The authors argue for a finer, chemistry-first way to match patients to care.
Catalog record
| CREATOR | Hakima Amri, Charles Sturgeon, David Posawatz, Mones Abu-Asab, Ryan R Collins, Simeng Suy, Sean P Collins, Giuseppe Lucarelli, Francesco Lasorsa |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |